Antiarrhythmic and Symptomatic Effect of ISIS CRP Rx Targeting CRP in Paroxysmal Atrial Fibrillation
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether treatment with ISIS CRP Rx can reduce AF
(Atrial Fibrillation) burden (percentage of time spent in AF) in subjects with paroxysmal AF